Hyaluronic Acid Raw Material Market To Reach $369.79 Million By 2033

Hyaluronic Acid Raw Material Market Growth & Trends

The global hyaluronic acid raw material market size is expected to reach USD 369.79 million by 2033, registering a CAGR of 5.25% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period. 

The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.

Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.

 Request a free sample copy or view report summary: Hyaluronic Acid Raw Material Market Report

Hyaluronic Acid Raw Material Market Report Highlights

• By application, the cosmetic & aesthetic applications segment dominated the market with a share of 55.87% in 2025. Nutraceutical & food supplement applications is the fastest-growing segment in the hyaluronic acid raw material industry.

• By grade, the cosmetic grade segment held the largest market share of 61.91% in 2025. The pharmaceutical (API) grade hyaluronic acid segment is the fastest-growing segment in the hyaluronic acid raw material market.

• By source, the non-animal hyaluronic acid segment dominated the market in 2025 and is expected to grow at the fastest CAGR over the forecast period.

• North America dominated the global market with a revenue share of 39.07% in 2025. The U.S. hyaluronic acid raw material market is experiencing strong growth driven by innovation across science, healthcare, and wellness sectors.

Hyaluronic Acid Raw Material Market Segmentation

Grand View Research has segmented global hyaluronic acid raw material market report based on application, source, grade, and region:

Hyaluronic Acid Raw Material Application Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Medical Applications

  • Ophthalmology

    • Cataract surgery (as ophthalmic viscoelastic devices - OVDs)

    • Aqueous eye drops (for lubrication and corneal protection)

    • Contact lens hydration

  • Orthopedics

    • Viscosupplements

    • Bone regeneration (as scaffolds and fillers in orthopedic implants)

  • Dermatology (Medical use)

    • Advance Wound Healing (HA-based dressings and gels)

  • Surgical / Medical Uses

    • Surgical adhesion prevention (HA-based anti-adhesive gels and membranes)

    • Medical device coating (for biocompatibility and lubrication)

  • Biomaterials and Implants

  • Cell and Tissue Preservation

• Cosmetic & Aesthetic Applications

  • Dermatology (Aesthetic use)

    • Intradermal (cosmetic injectables)

    • Dermal filler (aesthetic fillers)

  • Cosmetic / Personal Care (Creams, serums, moisturizers, lotions)

• Nutraceutical & Food Supplement Applications

• Other / Emerging Industrial Applications

  • Drug Delivery Systems (HA-based carriers for APIs)

  • Biomaterials (R&D) [Smart hydrogels, nanomaterials]

  • Other

Hyaluronic Acid Raw Material Source Outlook (Revenue, USD Million, 2021 - 2033)

• Non-Animal

• Animal

Hyaluronic Acid Raw Material Grade Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical (API) Grade (Orthopedic & others)

• Cosmetic Grade

• Food Grade

• Other (research-grade HA)

Hyaluronic Acid Raw Material Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Hyaluronic Acid Raw Material Market

• Bloomage Biotech

• HTL Biotechnology

• Fidia Farmaceutici S.p.A.

• Contipro a.s.

• Seikagaku Corporation

• Lifecore Biomedical, Inc.

• Kewpie Corporation

• Shandong Focuschem Biotech Co., Ltd.

• Shandong Freda Biopharm Co., Ltd.

• Shandong Topscience Biotech Co., Ltd.